'Subcutaneous furosemide in advanced heart failure: service improvement project'.

Francesca BirchEmily BoamSharon ParsonsJustin GhoshMiriam J Johnson

Published in: BMJ supportive & palliative care (2021)

These preliminary data indicate that CSCI-furosemide is safe and effective for people with severe heart failure. An adequately powered randomised controlled trial is indicated.

Keyphrases

heart failure
left ventricular
healthcare
mental health
study protocol
acute heart failure
cardiac resynchronization therapy
quality improvement
atrial fibrillation
electronic health record
big data
early onset
machine learning
randomized controlled trial
double blind